Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

145 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.
Postow MA, Sidlow R, Hellmann MD. Postow MA, et al. N Engl J Med. 2018 Jan 11;378(2):158-168. doi: 10.1056/NEJMra1703481. N Engl J Med. 2018. PMID: 29320654 Review. No abstract available.
Beyond cancer vaccines: a reason for future optimism with immunomodulatory therapy.
Postow M, Callahan MK, Wolchok JD. Postow M, et al. Cancer J. 2011 Sep-Oct;17(5):372-8. doi: 10.1097/PPO.0b013e31823261db. Cancer J. 2011. PMID: 21952288 Free PMC article. Review.
Chemotherapy in the Rwandan countryside: universal issues a world away.
Postow M. Postow M. Ann Intern Med. 2012 Jan 3;156(1 Pt 1):60-1. doi: 10.7326/0003-4819-156-1-201201030-00014. Ann Intern Med. 2012. PMID: 22213499 No abstract available.
The antitumor immunity of ipilimumab: (T-cell) memories to last a lifetime?
Postow MA, Callahan MK, Wolchok JD. Postow MA, et al. Clin Cancer Res. 2012 Apr 1;18(7):1821-3. doi: 10.1158/1078-0432.CCR-12-0409. Epub 2012 Feb 15. Clin Cancer Res. 2012. PMID: 22338019
Immunologic correlates of the abscopal effect in a patient with melanoma.
Postow MA, Callahan MK, Barker CA, Yamada Y, Yuan J, Kitano S, Mu Z, Rasalan T, Adamow M, Ritter E, Sedrak C, Jungbluth AA, Chua R, Yang AS, Roman RA, Rosner S, Benson B, Allison JP, Lesokhin AM, Gnjatic S, Wolchok JD. Postow MA, et al. N Engl J Med. 2012 Mar 8;366(10):925-31. doi: 10.1056/NEJMoa1112824. N Engl J Med. 2012. PMID: 22397654 Free PMC article.
Targeting immune checkpoints: releasing the restraints on anti-tumor immunity for patients with melanoma.
Postow MA, Harding J, Wolchok JD. Postow MA, et al. Cancer J. 2012 Mar-Apr;18(2):153-9. Cancer J. 2012. PMID: 22453017 Free PMC article. Review.
Immunomodulatory therapy for melanoma: ipilimumab and beyond.
Callahan MK, Postow MA, Wolchok JD. Callahan MK, et al. Among authors: postow ma. Clin Dermatol. 2013 Mar-Apr;31(2):191-9. doi: 10.1016/j.clindermatol.2012.08.006. Clin Dermatol. 2013. PMID: 23438382 Free PMC article. Review.
Ipilimumab for patients with advanced mucosal melanoma.
Postow MA, Luke JJ, Bluth MJ, Ramaiya N, Panageas KS, Lawrence DP, Ibrahim N, Flaherty KT, Sullivan RJ, Ott PA, Callahan MK, Harding JJ, D'Angelo SP, Dickson MA, Schwartz GK, Chapman PB, Gnjatic S, Wolchok JD, Hodi FS, Carvajal RD. Postow MA, et al. Oncologist. 2013 Jun;18(6):726-32. doi: 10.1634/theoncologist.2012-0464. Epub 2013 May 28. Oncologist. 2013. PMID: 23716015 Free PMC article.
Nivolumab plus ipilimumab in advanced melanoma.
Wolchok JD, Kluger H, Callahan MK, Postow MA, Rizvi NA, Lesokhin AM, Segal NH, Ariyan CE, Gordon RA, Reed K, Burke MM, Caldwell A, Kronenberg SA, Agunwamba BU, Zhang X, Lowy I, Inzunza HD, Feely W, Horak CE, Hong Q, Korman AJ, Wigginton JM, Gupta A, Sznol M. Wolchok JD, et al. Among authors: postow ma. N Engl J Med. 2013 Jul 11;369(2):122-33. doi: 10.1056/NEJMoa1302369. Epub 2013 Jun 2. N Engl J Med. 2013. PMID: 23724867 Free PMC article. Clinical Trial.
Checkpoint modulation in melanoma: an update on ipilimumab and future directions.
Page DB, Postow MA, Callahan MK, Wolchok JD. Page DB, et al. Among authors: postow ma. Curr Oncol Rep. 2013 Oct;15(5):500-8. doi: 10.1007/s11912-013-0337-1. Curr Oncol Rep. 2013. PMID: 23933888 Free PMC article. Review.
145 results
Jump to page